Medical cannabis company MGC Pharmaceuticals has agreed to sell two African-based exploration permits and related data for $500,000 in cash. The legacy mining assets no longer form part of the company's core business focus as it finalises the transition away from mineral exploration as Erin Resources and into a leading edge medical marijuana company.
11/08/2016 - 19:56
MGC Pharmaceuticals banks half a million from sale of legacy mining assets
By Matt Birney
11/08/2016 - 19:56
Related Data & Insights
-
MGC PharmaceuticalsClosing price for the last 90 trading daysPowered by Morningstar ®
-
Rank Company Revenue 125th MGC Pharmaceuticals $4.2m 126th Sterling Plantations $4.2m 127th International Equities Corporation $4.1m 129th ResApp Health $3.8m 130th Emyria $3.8m 200 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Data & Insights
Mentioned Organisations
Mentioned People
Related Articles
25 Mar 2024
Javelin to target Goldfields uranium anomaly
01 Mar 2024
Board Moves March 1, 2024
01 Dec 2023
Board Moves December 1, 2023
28 Jul 2023
Board Moves July 28, 2023
30 Jun 2023
MGC Pharma sacks senior staffer
Subscribe today for award-winning, unbiased and trusted journalism
Subscription OptionsX